IN8bio, Inc. (INAB)
1.64
+0.06
(+3.80%)
USD |
NASDAQ |
May 11, 14:47
IN8bio EPS Diluted (Quarterly) : -0.2615 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DiaMedica Therapeutics, Inc. | -0.1867 |
| Calidi Biotherapeutics, Inc. | -0.562 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.09M |
| Total Expenses (Quarterly) | 5.09M |
| Enterprise Value | -12.41M |
| Earnings Yield | -174.0% |
| Normalized Earnings Yield | -173.99 |